StockData
Accustem Sciences Inc. logo

Accustem Sciences Inc. (ACUT) stock

ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.15+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.37MP/E –Yield –

Accustem Sciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Accustem Sciences's free cash flow for the twelve months ending Dec 31, 2022 was -$1.82M. For fiscal 2022 it was -$1.82M.

Annual free cash flow

PeriodPeriod endValueChange
FY2022Dec 31, 2022-$1.82M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022-$622.26K–
Q3 FY2022Sep 30, 2022-$555.29K–
Q2 FY2022Jun 30, 2022-$1.00M–
Q1 FY2022Mar 31, 2022$363.78K–

More Accustem Sciences figures

See a number that looks wrong?